🇺🇸 FDA
Pipeline program

NNC0480-0389

NN9389-4680

Phase 1 small_molecule completed

Quick answer

NNC0480-0389 for Healthy Volunteers Type 2 Diabetes is a Phase 1 program (small_molecule) at Novo Nordisk A/S with 1 ClinicalTrials.gov record(s).

Program details

Company
Novo Nordisk A/S
Indication
Healthy Volunteers Type 2 Diabetes
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials